Entry into a Material Definitive Agreement

Quantum Cyber N.V. — Form 8-K Summary

Business context and reporting period

The company, incorporated in the Netherlands and listed on the Nasdaq Capital Market under QUCY, filed this current report on October 9, 2026. The filing reports an agreement for a potential at-the-market offering; it does not cover a quarterly or annual financial reporting period.

Offering and financial implications

  • Quantum Cyber may offer and sell up to $100 million of ordinary shares through Titan Partners Securities LLC under an existing effective Form S-3 shelf registration statement.
  • The company is not obligated to sell shares. The filing does not state that any shares have been sold or that proceeds have been received.
  • The sales agent will receive a commission of 3.0% of gross sales proceeds, and the company will reimburse certain specified expenses.
  • The filing provides no new revenue, profit, cash flow, margin, debt, or liquidity figures. It does not quantify the number of shares that may be issued.

Use of proceeds, outlook, and risks

If shares are sold, the company intends to use net proceeds for capital expenditures and software development for its motor, propeller, and quantum antenna lines; operating-system software development; production-capacity and product-offering expansion, potentially including acquisitions, investments, partnerships, or joint ventures; and working capital and general corporate purposes.

Sales may occur through Nasdaq or other trading markets, market makers, or negotiated transactions. The offering ends when all shares covered by the agreement are sold or the agreement is terminated. The company cautions that sales and intended use of proceeds are forward-looking and may not occur as expected. It cites economic and financial-market conditions and risks described in its prior SEC filings.

Most important facts for investors to verify

  • Whether and when shares are sold, and the resulting gross and net proceeds.
  • The amount of share issuance and its potential dilution to existing shareholders.
  • Actual allocation of proceeds compared with the stated intended uses.
  • The terms of the Sales Agreement and prospectus supplement, including termination and expense provisions.
  • Current liquidity and other financial information in the company’s latest periodic filings; this 8-K does not provide those metrics.
Disclaimer:
This AI-generated summary by MetaQuotes is based on SEC filings and may contain errors. Verify important details against the original SEC filings.